Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

ConditionsBreast Cancer Molecular Pathway Deregulation Treatment

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

AgeNot listed

SponsorLiaquat University of Medical & Health Sciences

About this trial

This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC

Disqualifiers

patients received pre-operative chemotherapy or radiotherapy

Trial population

The population are women with early operable primary breast cancer underwent surgery without any prior treatment.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Molecular characterisation
Procedure/Surgery
All patients treated by surgery were included without any neoadjuvant therapy

Treatment groups

300 Participants

are divided into 1 treatment group

Group A: Early operable primary breast cancer1 intervention

Trial outcomes

Primary outcomes

Breast cancer specific survival in correlation with molecular pattern

Time frame

10 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Liaquat University of Medical & Health Sciences

Lead sponsor

Source ClinicalTrials.gov

Apply now